STAG3L5P-PVRIG2P-PILRB

Across TCGA pan-cancer cohorts, STAG3L5P-PVRIG2P-PILRB RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated STAG3L5P-PVRIG2P-PILRB data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher STAG3L5P-PVRIG2P-PILRB RNA is associated with better overall survival. In most high-consensus cancer types, elevated STAG3L5P-PVRIG2P-PILRB expression acts as an unfavorable survival marker, although some lineages such as BLCA and BRCA show a favorable association.

BLCA, KICH, and ACC are the cancer types where STAG3L5P-PVRIG2P-PILRB RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	All	0.519	0.323	<.001	120	view →
KICH	OS	Median	III,IV	0.468	1.000	.001	92	view →
ACC	DFS	Median	II,III,IV	0.355	0.710	<.001	77	view →
KIRC	DFS	Tertile	All	0.499	0.713	<.001	70	view →
COAD	OS	Tertile	All	0.384	0.747	<.001	65	view →
LGG	DFS	Median	All	0.285	0.465	<.001	42	view →
BRCA	OS	Tertile	All	0.664	0.480	<.001	32	view →
UVM	DFS	Quartile	III,IV	0.170	0.813	.003	27	view →
PAAD	OS	Quartile	All	0.543	0.246	.010	22	view →
PRAD	DFS	Median	All	0.823	0.942	<.001	14	view →
SKCM	DFS	Quartile	All	0.675	0.546	.018	11	view →
OV	DFS	Median	III,IV	0.490	0.571	.014	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

STAG3L5P-PVRIG2P-PILRB–BLCA (OS)

Open the BLCA breakdown →